Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari

Published: 15 April 2026

Research shows increased awareness that bowel screening helps prevent bowel cancer

By Dr Róisín McCarthy, Research Officer, National Screening Service

Understanding how people feel about screening helps us improve our services and reach more people.

We looked at our research from 2023 and 2024 to see what changed in terms of how people think about BowelScreen – Ireland’s free national bowel screening programme.

About the research

The research was carried out using online surveys with adults living in Ireland who are eligible for BowelScreen. It looked at people’s awareness of bowel screening, what motivates them to take part, and what might stop them taking part.

More people see screening as important

A positive finding is that more people now recognise the importance of bowel screening.

  • 96% of people in 2024 said bowel screening is important.
  • This is up from 86% in 2023.

Fear is still a barrier

Fear of finding something wrong is still the main reason people say would stop them from taking part in bowel screening:

  • 55% in 2024
  • 46% in 2023

What motivates people to take part

The research shows that peace of mind is a strong reason to take part:

  • 72% in 2024
  • 59% in 2023

Advice from a GP or healthcare professional has become much more influential as a motivator:

  • 59% in 2024
  • 37% in 2023

Changing views on the benefits of screening

People’s understanding of the benefits of bowel screening is evolving.

Early detection of cancer is still widely recognised (88% in 2024), but more people now understand that screening can help prevent bowel cancer:

  • 61% in 2024
  • 41% in 2023

This shows growing awareness that bowel screening is not just about finding bowel cancer early - it can help stop bowel cancer from developing.

Conclusion

This research helps us understand what matters to people so we can keep improving how we communicate, support people to take part and make screening accessible to everyone.


  • The 2023 survey was carried out by Empathy Research, and the 2024 survey by Core Research, on behalf of the HSE National Screening Service.
  • We would like to thank CSTAR at UCD for their support with analysing the data.